Laboratory Corporation of America Holdings
Key Drivers
- Cash Flow
- Margin Expansion
- Debt Load
AIAI Summary
Labcorp's improving specialty-testing mix, tighter health-system integration, and solid free cash flow make it a stronger long-term earnings story than the market is pricing in, but with valuation already fair and the chart still weak, the stock needs clean execution and a hold above key support to justify a re-rating.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Cash Flow
- •Margin Expansion
- •Debt Load
LH delivers steady margins, strong free cash flow, and manageable leverage, but its premium valuation and intangible-heavy balance sheet temper upside.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Failed rebound
- •Support test
Over the last month, LH has been in a bearish downtrend with lower highs, repeated rejection at $257-$258, and $250 now the key support to watch.
Repeated failures to hold $257-$258 after the late-April peak, signaling weakening buying momentum
Sentiment & News
Key News Insights:
- •Q1 Beat
- •Raised Guidance
- •Epic Expansion
Labcorp delivered a strong Q1 beat with a raised 2026 outlook, while continued partnership and digital-integration wins reinforce improving momentum.
This news is positive for LH, as better-than-expected results and an improved outlook suggest solid operational momentum and support a constructive near-term view
Similar Companies in Healthcare
Other companies in the same sector with AI ratings